248 related articles for article (PubMed ID: 31806049)
1. The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.
Schoof M; Launspach M; Holdhof D; Nguyen L; Engel V; Filser S; Peters F; Immenschuh J; Hellwig M; Niesen J; Mall V; Ertl-Wagner B; Hagel C; Spohn M; Lutz B; Sedlacik J; Indenbirken D; Merk DJ; Schüller U
Acta Neuropathol Commun; 2019 Dec; 7(1):199. PubMed ID: 31806049
[TBL] [Abstract][Full Text] [Related]
2. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
Korzus E
Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
[TBL] [Abstract][Full Text] [Related]
3. CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain.
Wang J; Weaver IC; Gauthier-Fisher A; Wang H; He L; Yeomans J; Wondisford F; Kaplan DR; Miller FD
Dev Cell; 2010 Jan; 18(1):114-25. PubMed ID: 20152182
[TBL] [Abstract][Full Text] [Related]
4. Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability.
Valor LM; Pulopulos MM; Jimenez-Minchan M; Olivares R; Lutz B; Barco A
J Neurosci; 2011 Feb; 31(5):1652-63. PubMed ID: 21289174
[TBL] [Abstract][Full Text] [Related]
5. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
Lopez-Atalaya JP; Gervasini C; Mottadelli F; Spena S; Piccione M; Scarano G; Selicorni A; Barco A; Larizza L
J Med Genet; 2012 Jan; 49(1):66-74. PubMed ID: 21984751
[TBL] [Abstract][Full Text] [Related]
6. iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability.
Alari V; Russo S; Terragni B; Ajmone PF; Sironi A; Catusi I; Calzari L; Concolino D; Marotta R; Milani D; Giardino D; Mantegazza M; Gervasini C; Finelli P; Larizza L
Stem Cell Res; 2018 Jul; 30():130-140. PubMed ID: 29883886
[TBL] [Abstract][Full Text] [Related]
7. Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.
Shim JH; Greenblatt MB; Singh A; Brady N; Hu D; Drapp R; Ogawa W; Kasuga M; Noda T; Yang SH; Lee SK; Rebel VI; Glimcher LH
J Clin Invest; 2012 Jan; 122(1):91-106. PubMed ID: 22133875
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome Analysis of iPSC-Derived Neurons from Rubinstein-Taybi Patients Reveals Deficits in Neuronal Differentiation.
Calzari L; Barcella M; Alari V; Braga D; Muñoz-Viana R; Barlassina C; Finelli P; Gervasini C; Barco A; Russo S; Larizza L
Mol Neurobiol; 2020 Sep; 57(9):3685-3701. PubMed ID: 32562237
[TBL] [Abstract][Full Text] [Related]
9. Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.
Viosca J; Lopez-Atalaya JP; Olivares R; Eckner R; Barco A
Neurobiol Dis; 2010 Jan; 37(1):186-94. PubMed ID: 19822209
[TBL] [Abstract][Full Text] [Related]
10. Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells.
Dutto I; Scalera C; Tillhon M; Ticli G; Passaniti G; Cazzalini O; Savio M; Stivala LA; Gervasini C; Larizza L; Prosperi E
Carcinogenesis; 2020 May; 41(3):257-266. PubMed ID: 31504229
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice.
Zheng F; Kasper LH; Bedford DC; Lerach S; Teubner BJ; Brindle PK
PLoS One; 2016; 11(1):e0146366. PubMed ID: 26730956
[TBL] [Abstract][Full Text] [Related]
12. Clinical and mutational spectrum in Korean patients with Rubinstein-Taybi syndrome: the spectrum of brain MRI abnormalities.
Lee JS; Byun CK; Kim H; Lim BC; Hwang H; Choi JE; Hwang YS; Seong MW; Park SS; Kim KJ; Chae JH
Brain Dev; 2015 Apr; 37(4):402-8. PubMed ID: 25108505
[TBL] [Abstract][Full Text] [Related]
13. Multiplex ligation-dependent probe amplification detection of an unknown large deletion of the CREB-binding protein gene in a patient with Rubinstein-Taybi syndrome.
Calì F; Failla P; Chiavetta V; Ragalmuto A; Ruggeri G; Schinocca P; Schepis C; Romano V; Romano C
Genet Mol Res; 2013 Jan; 12(3):2809-15. PubMed ID: 23315884
[TBL] [Abstract][Full Text] [Related]
14. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.
López M; García-Oguiza A; Armstrong J; García-Cobaleda I; García-Miñaur S; Santos-Simarro F; Seidel V; Domínguez-Garrido E
BMC Med Genet; 2018 Mar; 19(1):36. PubMed ID: 29506490
[TBL] [Abstract][Full Text] [Related]
15. Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry.
Ateca-Cabarga JC; Cosa A; Pallarés V; López-Atalaya JP; Barco Á; Canals S; Moratal D
Sci Rep; 2015 Nov; 5():16256. PubMed ID: 26543002
[TBL] [Abstract][Full Text] [Related]
16. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.
Kalkhoven E; Roelfsema JH; Teunissen H; den Boer A; Ariyurek Y; Zantema A; Breuning MH; Hennekam RC; Peters DJ
Hum Mol Genet; 2003 Feb; 12(4):441-50. PubMed ID: 12566391
[TBL] [Abstract][Full Text] [Related]
17. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.
Murata T; Kurokawa R; Krones A; Tatsumi K; Ishii M; Taki T; Masuno M; Ohashi H; Yanagisawa M; Rosenfeld MG; Glass CK; Hayashi Y
Hum Mol Genet; 2001 May; 10(10):1071-6. PubMed ID: 11331617
[TBL] [Abstract][Full Text] [Related]
18. Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly.
Yu S; Wu B; Qian Y; Zhang P; Lu Y; Dong X; Wang Q; Zhao X; Liu R; Zhou W; Wang H
Mol Genet Genomic Med; 2019 Dec; 7(12):e1009. PubMed ID: 31637876
[TBL] [Abstract][Full Text] [Related]
19. Introduction of a de novo Creb-binding protein gene mutation in sperm to produce a Rubinstein-Taybi syndrome model using inbred C57BL/6 mice.
Takagi T; Higashi Y; Asai M; Ishii S
Brain Res; 2020 Dec; 1749():147140. PubMed ID: 33022214
[TBL] [Abstract][Full Text] [Related]
20. Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.
Menke LA; ; Gardeitchik T; Hammond P; Heimdal KR; Houge G; Hufnagel SB; Ji J; Johansson S; Kant SG; Kinning E; Leon EL; Newbury-Ecob R; Paolacci S; Pfundt R; Ragge NK; Rinne T; Ruivenkamp C; Saitta SC; Sun Y; Tartaglia M; Terhal PA; van Essen AJ; Vigeland MD; Xiao B; Hennekam RC
Am J Med Genet A; 2018 Apr; 176(4):862-876. PubMed ID: 29460469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
